Clarity from Pfizer Inc this week on whether China's relaxation of its Zero-COVID policy and the surge in infections there will lead to a spike in demand for its antiviral Paxlovid could spur analysts to alter their 2023 sales forecasts for the treatment.
this week on whether China's relaxation of its Zero-COVID policy and the surge in infections there will lead to a spike in demand for its antiviral Paxlovid could spur analysts to alter their 2023 sales forecasts for the treatment.
Their current estimates for over $10 billion in 2023 Paxlovid sales is less than half the $22 billion Pfizer is expected to report for 2022, according to Refinitiv data. Growth in China could help offset expected declines elsewhere as many governments have built inventories of the two-drug treatment.BMO Capital Markets analyst Evan Seigerman has forecast about $8.7 billion in global sales for Paxlovid in 2023, including $1.
Pfizer's tiered pricing structure sets the Paxlovid cost based on a country's economy. The U.S. government, for example, has paid over $500 per course. Media reports suggest that the current price per course in China is 1,890 yuan, or around $280.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Brock Purdy's injury revealed; 49ers to get more clarity Monday: reportThe San Francisco 49ers believe quarterback Brock Purdy suffered a UCL injury during the NFC Championship loss to the Philadelphia Eagles.
Consulte Mais informação »
‘Shazam’ Star Zachary Levi Sparks Anti-Vaxxer Rumors With Pfizer TweetJust over a month ahead of the premiere of DC’s Shazam! premiere date, its star, Zachary Levi, tweeted that he “hardcore” agrees that Covid-19 vaccine maker Pfizer is a “real danger to the world.”
Consulte Mais informação »
Zachary Levi Says He Agrees That Pfizer Is a Danger to the WorldTwitter is piling onto Zachary Levi after he expressed an opinion that many are taking as anti-vaxx ... even though the 'Shazam!' actor is trying to distance himself from such a position.
Consulte Mais informação »
Longevity Startup VitaDAO Raises $4.1m, Backed By Pfizer, Balaji SrinivasanThe web transformed life as we know it, allowing new ways of working, solving problems, and distributing currency.
Consulte Mais informação »
China’s Box Office Soars With $993M in Holiday Sales, Topping Pre-Pandemic PeriodThe post-COVID return of Chinese consumers to the multiplex is encouraging news for a global economy looking for bright spots.
Consulte Mais informação »